NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its receipt of two additional purchase orders for its revolutionary BaroShear(TM) K45 processing system. According to the update, the BaroShear K45, based on the company’s proprietary Ultra Shear Technology(TM) (“UST”) platform, is a unique and powerful nanoemulsification system designed to resolve one of the CBD industry’s most critical problems: the extremely poor solubility of CBD Oil in water. “We fully appreciate both the challenges and the significant emerging market opportunity of having the ability to deliver CBD in a form that allows for greater absorption and enhanced bioavailability,” NanoPeak Solutions, Inc. President Bruce Leitch said in the news release. “Multiple scientific studies have indicated that CBD should be processed via nanoemulsion technology in order to be truly water soluble and resulting in consumer products possessing both shelf stability and consistent dosages. NanoPeak has spent significant time reviewing and assessing various nanoemulsification platforms and the Company has great confidence that PBI’s BaroShear K45 System will be instrumental in NanoPeak having the ability to offer the highest quality ingredients to be utilized in CBD products of all types.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer